Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue (£)

Bicycle Therapeutics revenue was $10.39 m in FY, 2020

Quarterly Revenue ($)

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020
Revenue£836.05 k£81.1 k£45 k$2.06 m$7.14 m$13.8 m$10.39 m
Q2, 2019Q3, 2019Q2, 2020Q3, 2020Q1, 2021
Revenue$1.52 m$614 k$1.57 m$3.84 m$1.81 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Bicycle Therapeutics revenue breakdown by business segment: 24.4% from Oxurion Agreement, 56.2% from Bioverativ Agreement and 19.4% from AstraZeneca Agreement

FY, 2018FY, 2017
Oxurion Agreement$1.74 m$815 k
Bioverativ Agreement$4.01 m$355 k
AstraZeneca Agreement$1.39 m$890 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu